Clinical Trial Update: Effect of Topical Sulforaphane on Skin Aging and With Ultraviolet and Visible Light Exposure [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 trial evaluating topical sulforaphane for skin aging under UV and visible light exposure is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Aging

Drugs mentioned

• Sulforaphane (topical) (sulforaphane)

Snippet

Sponsor: Johns Hopkins University | Conditions: Skin Aging | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING